Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts

Roberta Riccioni, Daniela Diverio, Gualtiero Mariani, Sonia Buffolino, Viviana Riti, Ernestina Saulle, Eleonora Petrucci, Michele Cedrone, Francesco Lo-Coco, Foà Robin, Cesare Peschle, Ugo Testa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We investigated the expression of Tie-2 in primary blasts from 111 patients with acute myeloid leukemia (AML) to evaluate a possible linkage between the expression of this receptor and the immunophenotypic and biologic properties of leukemic blasts. Tie-2 was expressed at moderate and high levels in 39 and 23 of 111 AMLs, respectively. The analysis of the immunophenotype clearly showed that Tie-2 expression in AML was associated with monocytic features. Interestingly, Tie-2 expression on AML blasts was associated with concomitant expression of other receptors for endothelial growth factors, such as vascular endothelial growth factor receptor 1 (VEGF-R1), -R2, and -R3. Tie-2+ AMLs were characterized by high blast cell counts at diagnosis, a high frequency of Flt3 mutations, and increased Flt3 expression. The survival of Tie-2+ AMLs is sustained through an autocrine pattern involving Angiopoietin-1 and Tie-2, as suggested by experiments showing induction of apoptosis in Tie-2+ AMLs by agents preventing the binding of angiopoietins to Tie-2. Finally, the in vitro growth of Tie-2+ AMLs in endothelial culture medium supplemented with VEGF and angiopoietins resulted in their partial endothelial differentiation. These observations suggest that Tie-2+ AMLs pertain to a mixed monocytic/endothelial lineage, derived from the malignant transformation of the normal counterpart represented by monocytic cells expressing endothelial markers. The autocrine angiopoietin/Tie-2 axis may represent a promising therapeutic target to improve the outcome of patients with monocytic AML.

Original languageEnglish
Pages (from-to)1862-1871
Number of pages10
JournalStem Cells
Volume25
Issue number8
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Vascular Endothelial Growth Factor Receptor
Acute Myeloid Leukemia
Angiopoietins
Angiopoietin-2
Angiopoietin-1
Vascular Endothelial Growth Factor Receptor-1
Mutation Rate
Vascular Endothelial Growth Factor A
Culture Media
Endothelial Cells
Cell Count
Apoptosis
Survival
Growth
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Angiopoietins
  • Endothelial cells
  • Tie-2
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cell Biology

Cite this

Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts. / Riccioni, Roberta; Diverio, Daniela; Mariani, Gualtiero; Buffolino, Sonia; Riti, Viviana; Saulle, Ernestina; Petrucci, Eleonora; Cedrone, Michele; Lo-Coco, Francesco; Robin, Foà; Peschle, Cesare; Testa, Ugo.

In: Stem Cells, Vol. 25, No. 8, 08.2007, p. 1862-1871.

Research output: Contribution to journalArticle

Riccioni, R, Diverio, D, Mariani, G, Buffolino, S, Riti, V, Saulle, E, Petrucci, E, Cedrone, M, Lo-Coco, F, Robin, F, Peschle, C & Testa, U 2007, 'Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts', Stem Cells, vol. 25, no. 8, pp. 1862-1871. https://doi.org/10.1634/stemcells.2006-0700
Riccioni, Roberta ; Diverio, Daniela ; Mariani, Gualtiero ; Buffolino, Sonia ; Riti, Viviana ; Saulle, Ernestina ; Petrucci, Eleonora ; Cedrone, Michele ; Lo-Coco, Francesco ; Robin, Foà ; Peschle, Cesare ; Testa, Ugo. / Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts. In: Stem Cells. 2007 ; Vol. 25, No. 8. pp. 1862-1871.
@article{fcc0b644fe2745c5ba1f768ceeddc65e,
title = "Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts",
abstract = "We investigated the expression of Tie-2 in primary blasts from 111 patients with acute myeloid leukemia (AML) to evaluate a possible linkage between the expression of this receptor and the immunophenotypic and biologic properties of leukemic blasts. Tie-2 was expressed at moderate and high levels in 39 and 23 of 111 AMLs, respectively. The analysis of the immunophenotype clearly showed that Tie-2 expression in AML was associated with monocytic features. Interestingly, Tie-2 expression on AML blasts was associated with concomitant expression of other receptors for endothelial growth factors, such as vascular endothelial growth factor receptor 1 (VEGF-R1), -R2, and -R3. Tie-2+ AMLs were characterized by high blast cell counts at diagnosis, a high frequency of Flt3 mutations, and increased Flt3 expression. The survival of Tie-2+ AMLs is sustained through an autocrine pattern involving Angiopoietin-1 and Tie-2, as suggested by experiments showing induction of apoptosis in Tie-2+ AMLs by agents preventing the binding of angiopoietins to Tie-2. Finally, the in vitro growth of Tie-2+ AMLs in endothelial culture medium supplemented with VEGF and angiopoietins resulted in their partial endothelial differentiation. These observations suggest that Tie-2+ AMLs pertain to a mixed monocytic/endothelial lineage, derived from the malignant transformation of the normal counterpart represented by monocytic cells expressing endothelial markers. The autocrine angiopoietin/Tie-2 axis may represent a promising therapeutic target to improve the outcome of patients with monocytic AML.",
keywords = "Acute myeloid leukemia, Angiopoietins, Endothelial cells, Tie-2, Vascular endothelial growth factor",
author = "Roberta Riccioni and Daniela Diverio and Gualtiero Mariani and Sonia Buffolino and Viviana Riti and Ernestina Saulle and Eleonora Petrucci and Michele Cedrone and Francesco Lo-Coco and Fo{\`a} Robin and Cesare Peschle and Ugo Testa",
year = "2007",
month = "8",
doi = "10.1634/stemcells.2006-0700",
language = "English",
volume = "25",
pages = "1862--1871",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "8",

}

TY - JOUR

T1 - Expression of tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts

AU - Riccioni, Roberta

AU - Diverio, Daniela

AU - Mariani, Gualtiero

AU - Buffolino, Sonia

AU - Riti, Viviana

AU - Saulle, Ernestina

AU - Petrucci, Eleonora

AU - Cedrone, Michele

AU - Lo-Coco, Francesco

AU - Robin, Foà

AU - Peschle, Cesare

AU - Testa, Ugo

PY - 2007/8

Y1 - 2007/8

N2 - We investigated the expression of Tie-2 in primary blasts from 111 patients with acute myeloid leukemia (AML) to evaluate a possible linkage between the expression of this receptor and the immunophenotypic and biologic properties of leukemic blasts. Tie-2 was expressed at moderate and high levels in 39 and 23 of 111 AMLs, respectively. The analysis of the immunophenotype clearly showed that Tie-2 expression in AML was associated with monocytic features. Interestingly, Tie-2 expression on AML blasts was associated with concomitant expression of other receptors for endothelial growth factors, such as vascular endothelial growth factor receptor 1 (VEGF-R1), -R2, and -R3. Tie-2+ AMLs were characterized by high blast cell counts at diagnosis, a high frequency of Flt3 mutations, and increased Flt3 expression. The survival of Tie-2+ AMLs is sustained through an autocrine pattern involving Angiopoietin-1 and Tie-2, as suggested by experiments showing induction of apoptosis in Tie-2+ AMLs by agents preventing the binding of angiopoietins to Tie-2. Finally, the in vitro growth of Tie-2+ AMLs in endothelial culture medium supplemented with VEGF and angiopoietins resulted in their partial endothelial differentiation. These observations suggest that Tie-2+ AMLs pertain to a mixed monocytic/endothelial lineage, derived from the malignant transformation of the normal counterpart represented by monocytic cells expressing endothelial markers. The autocrine angiopoietin/Tie-2 axis may represent a promising therapeutic target to improve the outcome of patients with monocytic AML.

AB - We investigated the expression of Tie-2 in primary blasts from 111 patients with acute myeloid leukemia (AML) to evaluate a possible linkage between the expression of this receptor and the immunophenotypic and biologic properties of leukemic blasts. Tie-2 was expressed at moderate and high levels in 39 and 23 of 111 AMLs, respectively. The analysis of the immunophenotype clearly showed that Tie-2 expression in AML was associated with monocytic features. Interestingly, Tie-2 expression on AML blasts was associated with concomitant expression of other receptors for endothelial growth factors, such as vascular endothelial growth factor receptor 1 (VEGF-R1), -R2, and -R3. Tie-2+ AMLs were characterized by high blast cell counts at diagnosis, a high frequency of Flt3 mutations, and increased Flt3 expression. The survival of Tie-2+ AMLs is sustained through an autocrine pattern involving Angiopoietin-1 and Tie-2, as suggested by experiments showing induction of apoptosis in Tie-2+ AMLs by agents preventing the binding of angiopoietins to Tie-2. Finally, the in vitro growth of Tie-2+ AMLs in endothelial culture medium supplemented with VEGF and angiopoietins resulted in their partial endothelial differentiation. These observations suggest that Tie-2+ AMLs pertain to a mixed monocytic/endothelial lineage, derived from the malignant transformation of the normal counterpart represented by monocytic cells expressing endothelial markers. The autocrine angiopoietin/Tie-2 axis may represent a promising therapeutic target to improve the outcome of patients with monocytic AML.

KW - Acute myeloid leukemia

KW - Angiopoietins

KW - Endothelial cells

KW - Tie-2

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=34547916822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547916822&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2006-0700

DO - 10.1634/stemcells.2006-0700

M3 - Article

C2 - 17446561

AN - SCOPUS:34547916822

VL - 25

SP - 1862

EP - 1871

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 8

ER -